Skip to content
10-Q

Quarterly Report

ARCTURUS THERAPEUTICS HOLDINGS INC. ARCT

0001193125-26-211943

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 5, 2026 28.42M sh
Shares Diluted Q1 2026 · Mar 31, 2026 28.42M sh
Shares Diluted Q1 2026 · Mar 31, 2025 27.11M sh
Capex Q1 2026 · Mar 31, 2026 $0
Capex Q1 2026 · Mar 31, 2025 $137K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$19.44M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$35.14M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $211.38M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $230.91M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $216.95M
Stockholders Equity Q1 2026 · Mar 31, 2026 $191.36M
Stockholders Equity Q1 2026 · Dec 31, 2025 $213.99M
Stockholders Equity Q1 2026 · Mar 31, 2025 $233.76M
Stockholders Equity Q1 2026 · Dec 31, 2024 $240.98M
Current Liabilities Q1 2026 · Mar 31, 2026 $34.37M
Current Liabilities Q1 2026 · Dec 31, 2025 $36.38M
Total Liabilities Q1 2026 · Mar 31, 2026 $54.05M
Total Liabilities Q1 2026 · Dec 31, 2025 $57.16M
Current Assets Q1 2026 · Mar 31, 2026 $216.88M
Current Assets Q1 2026 · Dec 31, 2025 $241.45M
Total Assets Q1 2026 · Mar 31, 2026 $245.41M
Total Assets Q1 2026 · Dec 31, 2025 $271.15M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.95
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.52
Eps Basic Q1 2026 · Mar 31, 2026 −$0.95
Eps Basic Q1 2026 · Mar 31, 2025 −$0.52
Sga Expense Q1 2026 · Mar 31, 2026 $9.47M
Sga Expense Q1 2026 · Mar 31, 2025 $11.32M
Rd Expense Q1 2026 · Mar 31, 2026 $21.53M
Rd Expense Q1 2026 · Mar 31, 2025 $34.89M
Net Income Q1 2026 · Mar 31, 2026 −$26.96M
Net Income Q1 2026 · Mar 31, 2025 −$14.08M
Operating Income Q1 2026 · Mar 31, 2026 −$28.93M
Operating Income Q1 2026 · Mar 31, 2025 −$16.83M
Revenue Q1 2026 · Mar 31, 2026 $2.06M
Revenue Q1 2026 · Mar 31, 2025 $29.38M